FDA issued a Warning Letter to PharmScript, LLC on 8/23/2017 for a previous inspection.
483 PharmScript Aug 2018

483 PharmScript Aug 2018

Sena Dissmeyer FDA, Russell Glapion FDA$119.00 - Available Now

FDA investigators audited the PharmScript - Somerset, NJ, United States facility and issued inspectional observations (via FDA 483) on 07 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Aug 2018
  • Location: Somerset, United States
  • FEI: 3012837733
Add To Cart